Heart drug may stop PTSD before it starts in sexual assault survivors
NCT ID NCT07452978
First seen Mar 11, 2026 · Last updated Jun 13, 2026 · Updated 17 times
Summary
This study tests whether giving the drug propranolol (a beta-blocker) soon after a sexual assault can prevent post-traumatic stress disorder (PTSD). 34 adult women who seek help within 72 hours will take either propranolol or a placebo for 10 days, then a lower dose for another 14 days. Researchers will check for PTSD symptoms at 5 weeks using a standard interview. The idea is that propranolol may weaken the traumatic memory during its reconsolidation phase, reducing the risk of developing PTSD.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PTSD - POST TRAUMATIC STRESS DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.